This small-cap stock is expected to take off — if its weight-loss pill trial succeeds

by | Mar 29, 2024 | Stock Market

Terns Pharma is due to release data from an early-stage trial of an obesity treatment in pill form in the second half. Positive data would send the stock higher.

Article Attribution | Read More at Article Source

[mwai_chat context=”Let’s have a discussion about this article:nnTerns Pharma is due to release data from an early-stage trial of an obesity treatment in pill form in the second half. Positive data would send the stock higher.nnDiscussion:nn” ai_name=”RocketNews AI: ” start_sentence=”Can I tell you more about this article?” text_input_placeholder=”Type ‘Yes'”]
Share This